NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that it has filed a Premarket Approval Supplement (PMA-S) ...

A novel Kv7 potassium channel opener, may offer a unique treatment option for patients with resistant focal onset seizures.

Key Takeaways Artificial intelligence can improve treatment of epilepsyAI identified patients with drug-resistant epilepsy ...

A new advance from Carnegie Mellon University researchers could reshape how clinicians identify the brain regions responsible ...

AI-powered registries may improve epilepsy care by extracting data from incomplete medical records, easing the burden on clinicians when decisions are necessary regarding surgical evaluations, data ...

Taylor Hyma's journey from enduring drug-resistant epilepsy to becoming seizure-free after brain surgery highlights hope and ...

A pilot deployment of a generative artificial intelligence (AI) registry identified patients with drug-resistant epilepsy ...

The study was carried out by an international group of researchers including epilepsy experts from the Epilepsy Society’s Chalfont Centre. It is believed to be the longest single-centre follow-up of ...

The multidisciplinary epilepsy surgical conference review frequently alters SOZ interpretation and surgical plans for drug-resistant epilepsy.

Epilepsygtx Ltd. has raised a $33 million series A to fund a phase I/IIa trial of EPY-201, a gene therapy for treating ...

A new advance from Carnegie Mellon University researchers could reshape how clinicians identify the brain regions responsible for drug-resistant ...